Karşıyaka Prevalance and Awareness of Hypertension Study (KARHIP)

Nihat Pekel, Mehmet Emre Özpelit, Ebru Özpelit, Serkan Yakan, Caner Topaloğlu, Kamil Tülüce, Nurullah Çetin, Cihan Altın, Aydan Çelebiler, Serkan Saygı, İstemihan Tengiz, Ertuğrul Ercan

Abstract


Background: The study was planned to assess potential differences in hypertension prevalance and hypertension related demographic properties in a urban area with relatively higher income and cultural population compared to national average. Methods: Field work was done by educated personel at Karşıyaka Municipality Building by one by one interviewing poll, blood pressure measurement, rhythm and body composition analysis in February 2014. Hypertension was defined as  average  systolic blood pressure ≥140 mmHg or  average diastolic blood pressure ≥90 mmHg. Results: Out of total 1417 (627 males and 790 females) people enrolled, 780 people hypertensive(prevalence 55%). Hypertension prevalence in middle age group( age 35-65) was 46%, in geriatric age group(age>65) %79. 216 out of 780 hypertensive  (27.7%) people were not aware of their disease. Ratio of people under antihypertensive treatment was 69.4% and ratio of people under control was 34.7%, whereas control rate was 50.1% in 541 patients who were aware of their diseases.Conclusions: Hypertension prevalances in our study were similar to PatenT2 trial prevalances, which were  46 % for middle age group and 78% for geriatric age group. Compared to PatenT 2 data, rate of hypertension awareness (54.7% vs 72.3%) and rate of being under treatment (47.5% vs 69.4%) were higher. Rate of controlled hypertension was a little big higher (28.7 % vs 34.7% )in our group, whereas  control rates  in aware and treated groups were similar (53.9 % and 50.1 %) in both study. Keywords: Hypertension, Prevalance, Awareness, Treatment

 


Keywords


Hypertension, Prevalance, Awareness, Treatment

Full Text:

Pekel 316 pp73-78 HTML

References


Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005 Jan 15-21; 365:217-23. doi: 10.1016/S0140-6736(05)17741-1

Lawes CM, VanderHoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008 May 3; 371:1513-8. doi: 10.1016/S0140-6736(08)60655-8.

Turkish Statistical Institute: Causes of Death Statistics, 2012. Available at: http://www.turkstat.gov.tr/PreHaberBultenleri.do?id=15847.

Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, at all. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005; 23:1817-23.

Sengul S, Erdem Y, Akpolat T, Derici U, Sindel S, Karatan O, et al. Controlling hypertension in Turkey: not a hopeless dream. Kidney Int Suppl 2013; 3:326–31. doi: 10.1038/kisup.2013.68

Taylor J. 2013 ESH/ESC guidelines for the management of arterial hypertension. EurHeart J 2013 Jul; 34:2108-9

Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156:1–10.

Satman I, Yilmaz T, Sengul A, at all. The TURDEP Group. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002; 25:1551–6. doi: 10.2337/diacare.25.9.1551

Satman I, Omer B, Tutuncu Y, at all; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013 Feb; 28:169-80. doi: 10.1007/s10654-013-9771-5

Ünal B, Ergör G, editors. Chronic Diseases and Risk Factors Survey in Turkey. MoH. Ankara, 2013. Available from: URL: http://sbu.saglik.gov.tr/Ekutuphane/kitaplar/khrfat.pdf

Sönmez HM, Başak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, at all. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey. J Hum Hypertens 1999 Jun; 13:399-404

Tugay Aytekin N, Pala K, Irgil E, Akis N, Aytekin H. Distribution of blood pressures in Gemlik District, north-west Turkey. Health Soc Care Community 2002; 10: 394-401. doi: 10.1046/j.1365-2524.2002.00379.x

Gundogmus A, Oguz A, Cinar Y, Gundogmus U, Seref B. Prevalence, Awareness, Treatment, And Control Of Hypertensıon In Turkey The Kocaelı Study: Journal of Hypertension Issue: Volume 18 Supplement 2, June 2000, p S166

Ahmet Sarıışık, Aytekin Oğuz, Mehmet Uzunlulu. Control of hypertension in Turkey – is it improving? The Kocaeli 2 study. Arch Turk Soc Cardiol 2009; 37 Suppl 6:13-6.

Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health 2009 Mar; 31:47-58.

Ünal B, Sözmen K, Uçku R, Ergör G, Soysal A, Baydur H, at all. High prevalence of cardiovascular risk factors in a Western urban Turkish population: a community-based study. Anadolu Kardiyol Derg 2013 Feb; 13:9-17.

Baltaci D, Erbilen E, Turker Y, Alemdar R, Aydin M, Kaya A, at all. Predictors of hypertension control in Turkey: the MELEN study. Eur Rev Med Pharmacol Sci 2013 Jul; 17:1884-8.

Wolf-Maier K, Cooper RS, Banegas JR, at all. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003 May 14; 289:2363-9.

Oto MA, Ergene O, Tokgözoğlu L, at all. Impact of a mass media campaign to increase public awareness of hypertension. Arch Turk Soc Cardiol 2011 Jul; 39:355-64.

Mahley RW, Palaoğlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36:839-59.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4.




DOI: https://doi.org/10.17987/icfj.v8i0.316

Copyright (c) 2016 Nihat Pekel, Mehmet Emre Özpelit, Ebru Özpelit, Serkan Yakan, Caner Topaloğlu, Kamil Tülüce, Nurullah Çetin, Cihan Altın, Aydan Çelebiler, Serkan Saygı, İstemihan Tengiz, Ertuğrul Ercan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.